Skip to main content
. 2021 Jun 9;8:679171. doi: 10.3389/fmed.2021.679171

Table 1.

Characteristics of SLC12A3 mutation among 10 patients with Gitelman syndrome.

Patients Genotypes Nucleotide change (NM_000339.3) AA change (NP_000330.3) Topological localization
1 Compound heterozygous c.1924C>T + c.2548+253 p.R642C + Intronic Transmembrane + C-terminal
2 Homozygous c.1670-191C>T + c.1670-C>T Intronic + Intronic Transmembrane + Transmembrane
3 Compound heterozygous c.2875_76delAG + c.2548+253 p.R959fs + Intronic C-terminal + C-terminal
4 Compound heterozygous c.2129C>A + c.2875-76delAG p.S710X + p.R959fs C-terminal + C-terminal
5 Compound heterozygous c.488C>T+c.2660+1G>A p.T163M + splicing Transmembrane + C-terminal
6 Compound heterozygous c.1000C>T+c.1326C>G p.R334W + p.N442K Transmembrane + Transmembrane
7 Homozygous c.1670-191C>T + c.1670-C>T Intronic+ Intronic Transmembrane + Transmembrane
8 Compound heterozygous c.2129C>A + c.2875_76delAG p.S710X + p.R959fs C-terminal + C-terminal
9 Compound heterozygous c.911C>T/c.2875_76delAG p.T304M + p.R959fs Transmembrane + C-terminal
10 Compound heterozygous c.2532G>A+c.805-06insTTGGCGTGGTCTCGG p.W844X + p.T269delinsIGVVSA C-terminal + Transmembrane